1947
DOI: 10.1016/0002-8703(47)90347-5
|View full text |Cite
|
Sign up to set email alerts
|

Comparative study of potassium thiocyanate and other drugs in the treatment of essential hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

1950
1950
2015
2015

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 26 publications
0
3
0
Order By: Relevance
“…SCN treated patients were commonly observed with plasma SCN values of 400–2000 μM, with additional case reports of far higher concentrations in the literature, up to 7 mM [62,63]. Oral administration of SCN produces nearly 100% absorption in healthy subjects [28].…”
Section: Clinical History and Outcomes Of Thiocyanate Administrationmentioning
confidence: 99%
See 1 more Smart Citation
“…SCN treated patients were commonly observed with plasma SCN values of 400–2000 μM, with additional case reports of far higher concentrations in the literature, up to 7 mM [62,63]. Oral administration of SCN produces nearly 100% absorption in healthy subjects [28].…”
Section: Clinical History and Outcomes Of Thiocyanate Administrationmentioning
confidence: 99%
“…In the same study, patients receiving up to 600 mg per day had a median plasma level of 1500–2250 μM SCN [65]. However in another study the authors did not find significant difference in blood pressure reduction from placebo except at plasma levels that were regarded as unsafe [63]. Cardiac pathology also correlated inversely with therapeutic efficacy of SCN so that hypertensive subjects with the least chronic disease symptoms were the most likely to experience benefits [65].…”
Section: Clinical History and Outcomes Of Thiocyanate Administrationmentioning
confidence: 99%
“…Most striking are the consistently high values of SCN − in patient plasma, which were regularly maintained in a purported therapeutic range of 1.2-2.1 mM. In the few placebo-controlled trials from the contemporary literature, orally administered SCN − was only modestly more effective than placebo at lowering blood pressure [163,164]. Few if any clinical studies utilizing exogenous SCN − with therapeutic intent are known to have taken place since these; however, a non-randomized non-placebo controlled trial concerning the potential deleterious effect of exogenous SCN − on thyroid function in a susceptible population of Sudanese individuals has been published [50].…”
Section: Clinical and In Vivo Research On The Health Effects Of Scn−mentioning
confidence: 99%